Jason Shafrin, PhD, is the vice president of Health Economics at PRECISIONheor.
Quantifying the Insurance Value for Rare Diseases: Duchenne Muscular Dystrophy
The degree to which novel value elements such as insurance value impact estimated treatment value for rare, severe genetic diseases such as Duchenne muscular dystrophy is unclear.
Contributor: Steps Health Professionals Can Take to Reduce Inequality in Health Outcomes
Jason Shafrin, PhD, serves as the vice president of Health Economics at PRECISIONheor, and Meena Venkatachalam, MSc, is the senior director of Health Economics at PRECISIONheor.